Clinical study on gastrointestinal stromal tumors (GIST) in Iceland, 1990-2003

Digestive Diseases and Sciences

Volumn 52, Issue 9, 2007, Pages 2249-2253

  Tryggvason, Geir ^a   Kristmundsson, Pórarinn ^a   Örvar, Kjartan ^b   Jónasson, Jón G ^a,c,d   Magnússon, Magnús K ^a   Gíslason, Hjörtur G ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b St Joseph's Hospital   (Iceland)

^c ICELANDIC CANCER REGISTRY   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Gastrointestinal stromal tumors; Prognosis; Symptoms

Indexed keywords

IMATINIB;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TRACT; HUMAN; ICELAND; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MESENCHYME; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TOTAL STOMACH RESECTION; TUMOR VOLUME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; ICELAND; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE; TIME FACTORS;

EID: 34547830320     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9248-4     Document Type: Article

References (15)

1. Kindblom L, Remotti H, Aldenborg F, Meis-Kindblom J (1998) Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152(5):1259-1269
2. Hirota S, Isozaki H, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y (1998) gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580
3. Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, Hibbard MK, Chen C-J, Xiao S, Tuveson D, Demetri GD, Fletcher CDM, Fletcher JA (2001) KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 61:8118-8121
4. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472-480
5. Tryggvason G, Gislason HG, Magnusson MK, Jonasson JG (2005) Gastrointestinal stromal tumors in Iceland 1990-2003: The Icelandic GIST Study, population based incidence and pathologic risk stratification study. Int J Cancer 117(1):289-293
6. Fletcher CDM, Berman JJ, Corless CL, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 33:459-465
7. Dematteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231(1):51-58
8. Crosby JA, Catton CN, Davis A, Couture J, O'Sullivan B, Kandel R, Swallow CJ (2001) Malignant gastrointestinal stromal tumors of the small intestine: A review of 50 cases from a prospective database. Ann Surg Oncol 8(1):50-59
9. Pierie J-PEN, Choudry U, Muzikansky A, Yong Yeap B, Souba WW, Ott MJ (2001) The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 136:383-389
10. Ng EH, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM (1992) Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 215(1):68-77
11. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ (1999) Prognosis of gastrointestinal smooth-muscle (stromal) tumors: Dependence on anatomic site. Am J Surg Pathol 23(1):82-87
12. Nilsson B, Bumming P, Kindblom JM, Odén A, Dortok A, Gustavsson B, Sablinska K, Kindblom L-G (2005) Gastrointestinal stromal tumors: The incidence, prevalence, clinical course and prognostication in the preimatinib mesylate era. Cancer 103:821-829
13. Antonescu CR, Sommer G, Sarran L, Tschernyavsky SJ, Riedel E, Woodruff JM, Robson M, Maki R, Brennan MF, Ladanyi M, Dematteo RP, Besmer P (2003) Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res 9:3329-3337
14. Lasota J, Dansonka-Miesakowska A, Sobin LH, Miettinen M (2004) A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab Invest 84:874-883
15. McGrath PC, Neifeld JP, Lawrence WJ, Kay S, Horsley JS, Parker GA (1987) Gastrointestinal sarcomas. Analysis of prognostic factors. Ann Surg 206(6):706-710